- BMRA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Biomerica (BMRA) CORRESPCorrespondence with SEC
Filed: 18 Jul 17, 12:00am
BIOMERICA, INC.
17571 Von Karman Ave.
Irvine, CA 92614
July 18, 2017
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
Re: Biomerica, Inc.
Registration Statement on Form S-3 (File No. 333-219130)
Acceleration Request
Requested Date: July 20, 2017
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), Biomerica, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Christopher D. Ivey, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4121 or via email at civey@sycr.com.
Sincerely, |
|
BIOMERICA, INC. |
|
/s/ Zackary Irani |
Zackary Irani |
Chairman and Chief Executive Officer |
cc:
Biomerica, Inc.
Janet Moore, Chief Financial Officer